Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatic beta-oxidation pathway enzymes are a group of proteins located in the mitochondria and peroxisomes of liver cells that catalyze the breakdown of fatty acids. These enzymes are essential for energy production, particularly during fasting or periods of high-fat intake, and play a critical role in maintaining lipid homeostasis. Key enzymes include acyl-CoA dehydrogenases, enoyl-CoA hydratases, hydroxyacyl-CoA dehydrogenases, ketoacyl-CoA thiolases (in mitochondria), acyl-coenzyme A oxidase (ACOX1), multifunctional protein (EHHADH/MFP1), and carnitine palmitoyltransferase I (CPT I). Deficiencies in these enzymes can lead to various metabolic disorders characterized by impaired energy production and lipid accumulation.
Inhibition or activation of specific enzymes within the beta-oxidation pathway to modulate fatty acid metabolism. For example, some drugs may inhibit CPT1 to reduce fatty acid entry into mitochondria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatic Beta-Oxidation Pathway Enzymes (N/A).